Preclinical News and Research

RSS
Scientists develop nanodevice to deliver immunotherapy without side effects

Scientists develop nanodevice to deliver immunotherapy without side effects

Hippocampal avoidance during whole-brain radiotherapy reduces risk of cognitive decline

Hippocampal avoidance during whole-brain radiotherapy reduces risk of cognitive decline

New partnership aims to tackle cancer health disparities

New partnership aims to tackle cancer health disparities

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

New 17-item questionnaire may help detect GI disorders in children with autism

New 17-item questionnaire may help detect GI disorders in children with autism

New topical gel can prevent pesticide-induced toxicity and lethality

New topical gel can prevent pesticide-induced toxicity and lethality

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress

ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

Mice study shows antibiotics are not always necessary to cure sepsis

Mice study shows antibiotics are not always necessary to cure sepsis

Researchers awarded grant to advance testing of experimental heroin vaccine

Researchers awarded grant to advance testing of experimental heroin vaccine

A new vaccine shows promise in protecting people from rabies, Lassa fever

A new vaccine shows promise in protecting people from rabies, Lassa fever

DNA vaccine shown to provide long-term protection from Ebola

DNA vaccine shown to provide long-term protection from Ebola

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Otago scientists make a breakthrough in monkey malaria research

Otago scientists make a breakthrough in monkey malaria research

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.